Your browser doesn't support javascript.
Clinico-demographic profile & hospital outcomes of COVID-19 patients admitted at a tertiary care centre in north India.
Mohan, Anant; Tiwari, Pawan; Bhatnagar, Sushma; Patel, Ankit; Maurya, Abhishek; Dar, Lalit; Pahuja, Sourabh; Garg, Rakesh; Gupta, Nishkarsh; Sahoo, Biswajeet; Gupta, Ritu; Meena, Ved Prakash; Vig, Saurabh; Pandit, Anuja; Mittal, Saurabh; Madan, Karan; Hadda, Vijay; Dwivedi, Tanima; Choudhary, Aashish; Brijwal, Megha; Soneja, Manish; Guleria, Randeep; Ratre, Brajesh; Kumar, Balbir; Bhopale, Shweta; Panda, Smriti; Singh, Angel Rajan; Singh, Sheetal; Wundavalli, Laxmitej.
  • Mohan A; Department of Pulmonary, Critical Care & Sleep Medicine, All India Institute of Medical Sciences, New Delhi, India.
  • Tiwari P; Department of Pulmonary, Critical Care & Sleep Medicine, All India Institute of Medical Sciences, New Delhi, India.
  • Bhatnagar S; Department of Onco-Anaesthesia & Palliative Medicine, All India Institute of Medical Sciences, New Delhi, India.
  • Patel A; Department of Pulmonary, Critical Care & Sleep Medicine, All India Institute of Medical Sciences, New Delhi, India.
  • Maurya A; Department of Pulmonary, Critical Care & Sleep Medicine, All India Institute of Medical Sciences, New Delhi, India.
  • Dar L; Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
  • Pahuja S; Department of Pulmonary, Critical Care & Sleep Medicine, All India Institute of Medical Sciences, New Delhi, India.
  • Garg R; Department of Onco-Anaesthesia & Palliative Medicine, All India Institute of Medical Sciences, New Delhi, India.
  • Gupta N; Department of Onco-Anaesthesia & Palliative Medicine, All India Institute of Medical Sciences, New Delhi, India.
  • Sahoo B; Department of Laboratory Oncology, National Cancer Institute, All India Institute of Medical Sciences, Jhajjar, Haryana, India.
  • Gupta R; Department of Hospital Administration, National Cancer Institute, All India Institute of Medical Sciences, Jhajjar, Haryana, India.
  • Meena VP; Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.
  • Vig S; Department of Onco-Anaesthesia & Palliative Medicine, All India Institute of Medical Sciences, New Delhi, India.
  • Pandit A; Department of Onco-Anaesthesia & Palliative Medicine, All India Institute of Medical Sciences, New Delhi, India.
  • Mittal S; Department of Pulmonary, Critical Care & Sleep Medicine, All India Institute of Medical Sciences, New Delhi, India.
  • Madan K; Department of Pulmonary, Critical Care & Sleep Medicine, All India Institute of Medical Sciences, New Delhi, India.
  • Hadda V; Department of Pulmonary, Critical Care & Sleep Medicine, All India Institute of Medical Sciences, New Delhi, India.
  • Dwivedi T; Department of Laboratory Oncology, National Cancer Institute, All India Institute of Medical Sciences, Jhajjar, Haryana, India.
  • Choudhary A; Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
  • Brijwal M; Department of Microbiology, All India Institute of Medical Sciences, New Delhi, India.
  • Soneja M; Department of Medicine, All India Institute of Medical Sciences, New Delhi, India.
  • Guleria R; All India Institute of Medical Sciences, New Delhi, India.
  • Ratre B; Department of Onco-Anaesthesia & Palliative Medicine, All India Institute of Medical Sciences, New Delhi, India.
  • Kumar B; Department of Onco-Anaesthesia & Palliative Medicine, All India Institute of Medical Sciences, New Delhi, India.
  • Bhopale S; Department of Onco-Anaesthesia & Palliative Medicine, All India Institute of Medical Sciences, New Delhi, India.
  • Panda S; Department of Otolaryngology & Head-Neck Surgery, All India Institute of Medical Sciences, New Delhi, India.
  • Singh AR; Department of Hospital Administration, All India Institute of Medical Sciences, New Delhi, India.
  • Singh S; Department of Hospital Administration, National Cancer Institute, All India Institute of Medical Sciences, Jhajjar, Haryana, India.
  • Wundavalli L; Department of Hospital Administration, National Cancer Institute, All India Institute of Medical Sciences, Jhajjar, Haryana, India.
Indian J Med Res ; 152(1 & 2): 61-69, 2020.
Article in English | MEDLINE | ID: covidwho-708771
ABSTRACT
BACKGROUND &

OBJECTIVES:

In December 2019, a novel coronavirus (SARS-CoV-2) emerged in China and rapidly spread globally including India. The characteristic clinical observations and outcomes of this disease (COVID-19) have been reported from different countries. The present study was aimed to describe the clinico-demographic characteristics and in-hospital outcomes of a group of COVID-19 patients in north India.

METHODS:

This was a prospective, single-centre collection of data regarding epidemiological, demographic, clinical and laboratory parameters, management and outcome of COVID-19 patients admitted in a tertiary care facility in north India. Patient outcomes were recorded as death, discharge and still admitted.

RESULTS:

Data of 144 patients with COVID-19 were recorded and analyzed. The mean age of the patients was 40.1±13.1 yr, with 93.1 per cent males, and included 10 (6.9%) foreign nationals. Domestic travel to or from affected States (77.1%) and close contact with COVID-19 patients in congregations (82.6%) constituted the most commonly documented exposure. Nine (6.3%) patients were smokers, with a median smoking index of 200. Comorbidities were present in 23 (15.9%) patients, of which diabetes mellitus (n=16; 11.1%) was the most common. A significant proportion of patients had no symptoms (n=64; 44.4%); among the symptomatic, cough (34.7%) was the most common symptom followed by fever (17.4%) and nasal symptoms (2.15%). Majority of the patients were managed with supportive treatment with hydroxychloroquine and azithromycin given on a case-to-case basis. Only five (3.5%) patients required oxygen supplementation, four (2.8%) patients had severe disease requiring intensive care, one required mechanical ventilation and mortality occurred in two (1.4%) patients. The time to reverse transcription-polymerase chain reaction (RT-PCR) negativity was 16-18 days. INTERPRETATION &

CONCLUSIONS:

In this single-centre study of 144 hospitalized patients with confirmed COVID-19 in north India, the characteristic findings included younger age, high proportion of asymptomatic patients, long time to PCR negativity and low need for intensive care unit care.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Tertiary Care Centers / Betacoronavirus Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: English Journal: Indian J Med Res Year: 2020 Document Type: Article Affiliation country: Ijmr.IJMR_1788_20

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Tertiary Care Centers / Betacoronavirus Type of study: Observational study / Prognostic study Topics: Long Covid Limits: Adult / Female / Humans / Male / Middle aged Country/Region as subject: Asia Language: English Journal: Indian J Med Res Year: 2020 Document Type: Article Affiliation country: Ijmr.IJMR_1788_20